Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Alzheimers Dement. 2014 Dec 20;11(6):658–671. doi: 10.1016/j.jalz.2014.05.1757

Table 1. Significant excess of enriched pathways remain after removing APOE and the genome-wide significant genes.

Genes removed (number of genes) enrichment p<0.05 enrichment p<0.01 enrichment p<0.001

#path p #path p #path p
None 542 <0.0002 177 <0.0002 40 <0.0002
APOE+1Mb (77) 446 0.0002 131 0.0006 28 0.0008
APOE+1Mb+GWS (98) 402 0.0020 116 0.0008 23 <0.0002
APOE+1Mb+GWS+1Mb (552) 336 0.0094 93 0.0066 22 0.0018

Genes containing a SNP with p<8.32×10-4 counted as significant. This corresponds to the top 5% of genes (ranked by most significant SNP) when no genes are removed. 0kb window used to assign SNPs to genes. #path = number of pathways